Nick B.
Founding Investor @Sernova
Signup · Get unlimited contacts
WORK HISTORY
Founding Investor @Sernova
London, ON, CA
Sernova is a clinical stage regenerative medicine company focused on developing & commercializing its platform technologies based on the Company’s proprietary Cell Pouch System (CPS), micro-encapsulation, genetic engineering (local anti-rejection control) & therapeutic cells. Sernova has licensed/partnered technologies from multiple world-class corporate & academic institutions related to the development of islets (xenogeniec & human) and stem cells into glucose-responsive therapeutic cells for the treatment of T-1 diabetes. The CPS is a novel, subcutaneously implantable & scalable business card-sized medical device scaffold, forming a natural environment in the body for the housing & long-term survival & function of therapeutic cells. As the CPS is fully integrated into the body’s vascular system, these therapeutic cells release necessary proteins, hormones or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs according to the body’s specific therapeutic needs when required – as per normal physiologic functioning. The CPS is ideally suited for allogeneic, autologous, stem cell & xenogeneic applications.Sernova\'s current FDA approved Ph. I/II Chicago-based trial goals for the CPS include clinically validating the ability to treat T-1 diabetes via donor islet transplantation to create endogenous production of insulin, somatostatin, and glucagon to control blood glucose without any external monitoring or insulin/hormonal sources. The primary long-term goal for the CPS is to provide a \"cure\" for T-1 diabetes by providing a safe, fully vascularized environment for sources of unlimited insulin-secreting cells. Pre-clinical work on the CPS is also underway to treat Hemophilia A with controlled endogenous production of Factor via Blood Origin Endothelial Derived Cells, as well as endogenous production of thyroid hormone for benign thyroid diseases. Pipeline applications include Parkinson\'s Disease.
EDUCATION
Massey University / Asia Pacific International Institute
M.B.A., International Business
Simon Fraser University
B.Sc., Kinesiology & Biological Sciences
ABOUT NICK B.
Currently an entrepreneur and active investor - Member of The International Trade…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.